The store will not work correctly when cookies are disabled.
3-(5-(2H-1,2,3,4-Tetrazol-5-yl)-1H-Indazol-3-yl)Thiophene
ID: ALA3986111
PubChem CID: 22479797
Max Phase: Preclinical
Molecular Formula: C12H8N6S
Molecular Weight: 268.31
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: c1cc(-c2n[nH]c3ccc(-c4nnn[nH]4)cc23)cs1
Standard InChI: InChI=1S/C12H8N6S/c1-2-10-9(5-7(1)12-15-17-18-16-12)11(14-13-10)8-3-4-19-6-8/h1-6H,(H,13,14)(H,15,16,17,18)
Standard InChI Key: BAWACFRRXKKDPX-UHFFFAOYSA-N
Molfile:
RDKit 2D
19 22 0 0 0 0 0 0 0 0999 V2000
12.4711 -8.5144 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4699 -9.3422 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1821 -9.7512 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1803 -8.1056 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8889 -8.5108 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8937 -9.3377 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6779 -9.5862 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1594 -8.9169 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.6701 -8.2534 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.7578 -9.7503 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0118 -9.4173 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.4605 -10.0254 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.8686 -10.7376 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.6719 -10.5695 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.9367 -10.3599 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4635 -11.0242 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9488 -11.6801 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7226 -11.4213 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
15.7155 -10.6054 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 5 1 0
2 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 10 1 0
7 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 1 0
19 15 2 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 268.31 | Molecular Weight (Monoisotopic): 268.0531 | AlogP: 2.47 | #Rotatable Bonds: 2 |
Polar Surface Area: 83.14 | Molecular Species: ACID | HBA: 5 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 4.28 | CX Basic pKa: 1.52 | CX LogP: 2.39 | CX LogD: 0.79 |
Aromatic Rings: 4 | Heavy Atoms: 19 | QED Weighted: 0.58 | Np Likeness Score: -2.40 |
References
1. (2002) Indazole derivatives as JNK inhibitors and compositions and methods related thereto, |